2.8K(top 7%)
articles
78.6K(top 6%)
citations
860(top 6%)
★★ articles
20(top 7%)
★★★ articles
2.4(top 22%)
Avg IF
117(top 6%)
H-Index
189(top 6%)
G-Index
929
journals

Most Cited Articles of Centre Hospitalier Régional et Universitaire de Lille

TitleJournalYearCitations
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaScience20151.7K
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trialLancet Oncology, The20181.1K
Defeating Alzheimer's disease and other dementias: a priority for European science and societyLancet Neurology, The2016921
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialLancet, The2014753
Fractal and multifractal analysis: a reviewMedical Image Analysis2009592
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre studyLancet Oncology, The2016576
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter studyArthritis and Rheumatism2005526
Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populationsNature Genetics2009521
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementLeukemia2010505
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapyGastroenterology2000493
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytosesBlood2012469
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failedGastroenterology2014468
Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failureCirculation Research2014448
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stoppedGastroenterology2012446
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyDiabetologia2020442
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroidsHepatology2007441
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapyImmunological Reviews2007431
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 studyLancet Oncology, The2019425
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialJAMA - Journal of the American Medical Association2014405
Neurologic manifestations in primary Sjögren syndrome: a study of 82 patientsMedicine (United States)2004401
Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trialJournal of Endovascular Therapy2006393
Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic herniaUltrasound in Obstetrics and Gynecology2007376
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory EffectsImmunity2016376
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemiasLeukemia2011369
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trialLancet, The2015356